Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

Pharmacists now have more guidance for combating the opioid crisis and providing treatment to patients, thanks to new ...

Higher doses of buprenorphine for patients with opioid use disorder (OUD) are associated with lower acute care utilization, ...

The first study, conducted in Mexico, found that ibogaine improved opioid withdrawal symptoms and reduced drug use in individuals who did not find success with previous treatment methods.

A bipartisan group of two dozen representatives pushed officials to preserve the pandemic-era prescribing changes for buprenorphine, arguing telehealth increases access and prevents overdoses.

A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of ...

Just 44 percent of jails offer incarcerated people with opioid use disorder medications like methadone, buprenorphine or ...

EpiVario, Inc., a biotech company pioneering novel therapeutics for memory-related psychiatric disorders, today announced it ...

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of ...

Sublocade is a long-acting form of buprenorphine, a medication for opioid use disorder. It’s given once a month as an ...

KOLs interviewed by GlobalData and surveyed prescribing physicians agreed that there is a gap in the market for safer ...

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of ...